What a Director’s Stock Purchase Can Tell Us About National Bankshares Ever wonder what it means when someone from a company’s board buys stock in their own business? It can actually be…
Author: James Anderson
With over 50 years of experience in the U.S. stock market, I’ve seen every cycle — bull runs, crashes, and everything in between. My journey began long before the internet age, grounded in fundamental analysis and refined through decades of real-world investing. Today, I run WallStreetGain.com, a platform dedicated to helping traders and investors make informed decisions with confidence. Whether you're just starting or managing a seasoned portfolio, my goal is to share timeless strategies, market insights, and the hard-earned lessons that only half a century in the markets can teach.
Westinghouse Air Brake EVP Sells Shares Worth $408,285
Westinghouse Air Brake Insider Sale: What It Means for Investors Have you ever wondered what it means when top executives at big companies sell off some of their shares? Does it signal…
Build-A-Bear Director Craig Leavitt Sells $414K in Stock
What Build-A-Bear Director Craig Leavitt’s Stock Sale Could Mean for Investors Insider trading might sound like a tricky term, but it’s something every smart investor should understand. Why? Because when top executives…
Sellas Life Sciences Director Buys $14,800 in Company Stock
Why a Director Buying Stock in Sellas Life Sciences Matters—and What It Could Mean for Investors Have you ever wondered what happens when company insiders start buying shares of their own stock?…
MCGlobalHub Enhances Financial Education With New Investor Tools
MCGlobalHub Steps Up: Fresh Investor Tools and Resources Make Financial Education Easier Than Ever Let’s be honest, navigating the world of investing can feel overwhelming—especially if you’re just getting started. Stocks, crypto,…
Lantern Pharma Major Shareholders Sell $208K in Company Stock
Lantern Pharma Stock Sales: What Investors Should Know About Insider Activity If you’re keeping a close eye on the biotech sector, you might have heard about recent insider selling at Lantern Pharma…
Enliven Therapeutics Raises $200 Million in Public Offering
Enliven Therapeutics Raises $200 Million: What It Means for Investors and the Future of Cancer Treatment Imagine you’re building something big—a life-saving innovation—but you need a hefty financial boost to get it…
Adobe Raises Outlook After Strong Fiscal Q2 Earnings Beat Expectations
Adobe Surprises Wall Street: What Its Strong Q2 Results Mean for Investors When it comes to creative software, Adobe is often the first name that pops into mind. From Photoshop to Acrobat,…
Oxford Instruments Shares Dip on Flat Orders and FX Pressures
Oxford Instruments Faces Bumpy Ride: Orders Slow and Currency Challenges Ahead It’s been a bit of a rollercoaster lately for Oxford Instruments (LON:OXIG), a UK-based technology company known for its high-precision tools…
FTSE 100 Opens Lower Amid Escalating Israel-Iran Tensions
Why the FTSE 100 Opened Lower Today — And What It Means for Investors Navigating Market Jitters Amid Middle East Tensions Have you checked the stock market today and wondered, “Why is…